Conference Coverage

Herpes zoster boosts short-term stroke, TIA risk


 

REPORTING FROM ACC 2018


Dr. Rausch’s study was sponsored by her employer, GlaxoSmithKline. The findings are supportive of an earlier study by other investigators, who found that the risk of hospitalization for stroke was up to twofold greater within the first 90 days after diagnosis of HZ in patients with rheumatoid arthritis and other autoimmune diseases than the stroke rate 366-730 days after HZ (Arthritis Rheumatol. 2017.69[2]:439-46).

SOURCE: Rausch DA. ACC 18

Pages

Recommended Reading

Thrombectomy’s success treating strokes prompts rethinking of selection criteria
MDedge Cardiology
Overweight and obese individuals face greater cardiovascular morbidity
MDedge Cardiology
200 cardiovascular drugs now in development
MDedge Cardiology
Trial shows ‘signals’ in favor of general anesthesia during EVT for stroke
MDedge Cardiology
MOMENTUM 3 HeartMate 3 LVAD ‘practice changing’
MDedge Cardiology
VIDEO: Patient vouchers prompt physicians to prescribe top antiplatelet drugs
MDedge Cardiology
Transporting stroke patients directly to thrombectomy boosts outcomes
MDedge Cardiology
Beware of polypharmacy in patients taking warfarin
MDedge Cardiology
VIDEO: Andexanet alfa effectively reverses factor Xa anticoagulant
MDedge Cardiology
VIDEO: PFO closure device 100% effective against future strokes
MDedge Cardiology

Related Articles